In summary, our results demonstrated that AIM2 expression was low in BRAF-mutant CRC, and restoration AIM2 expression in BRAF-mutant CRC cells could inhibit cancer cell growth in a caspase-1-dependent manner. The gene discussed is AIM2; the disease is colorectal carcinoma.